Nucleus Basalis of Meynert (NBM) Cholinergic Neurons

Nucleus Basalis of Meynert (NBM) Cholinergic Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus Basalis of Meynert (NBM) Cholinergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)</td>
</tr>
</table>

Introduction

Nucleus Basalis Of Meynert (Nbm) Cholinergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

Nucleus Basalis of Meynert (NBM) Cholinergic Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus Basalis of Meynert (NBM) Cholinergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)</td>
</tr>
</table>

Introduction

Nucleus Basalis Of Meynert (Nbm) Cholinergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The nucleus basalis of Meynert (NBM) is the primary source of cholinergic innervation to the cerebral cortex and represents one of the most critical systems for cognitive function. Located in the basal forebrain, these large cholinergic neurons project extensively throughout the cortical mantle, modulating arousal, attention, learning, and memory. The severe degeneration of NBM neurons in Alzheimer's disease (AD) and the resulting cholinergic deficit represent one of the best-characterized neurochemical hallmarks of dementia, forming the basis for current symptomatic treatments [@coyle1983].

Overview

Nucleus Basalis Cholinergic Neurons are specialized neurons in the brain that play important roles in neurological function and are relevant to neurodegenerative diseases. These neurons are involved in critical processes such as neurotransmitter regulation, autonomic control, or sensory processing.

Dysfunction or degeneration of these neurons contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders through effects on neurotransmitter systems, cellular metabolism, or neural circuit function.
<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: cholinergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Location and Anatomy

The NBM is located in the basal forebrain, spanning multiple interconnected structures:

• Substantia innominata: The primary location of NBM cholinergic neurons
• Horizontal limb of the diagonal band of Broca: Continuous with the NBM
• Nucleus of the ansa lenticularis: Ventral extension

The human NBM contains approximately 150,000-200,000 large, magnocellular cholinergic neurons. These neurons have extensive axonal arborizations that innervate virtually the entire cortical mantle, with denser projections to:

• Prefrontal cortex (attention and executive function)
• Parietal cortex (spatial processing)
• Temporal cortex (memory and language)
• Hippocampus (explicit memory)
• Olfactory bulb (unique among basal forebrain regions)

The NBM is part of the larger basal forebrain cholinergic system (BFCS), which also includes the medial septal nucleus (MS) and vertical diagonal band of Broca (VDB) that project to the hippocampus [@mesulam1985].

Molecular Markers

Choline Acetyltransferase (ChAT)

The enzyme catalyzing acetylcholine synthesis from acetyl-CoA and choline, ChAT is the definitive marker for cholinergic neurons. Its activity directly correlates with cholinergic neuron viability [@kasa1997].

Acetylcholinesterase (AChE)

The hydrolyzing enzyme for acetylcholine, AChE is highly expressed in cholinergic neurons and represents both a marker and functional component.

p75NTR (NGFR, p75 Neurotrophin Receptor)

The pan-neurotrophin receptor (p75NTR) is expressed on NBM neurons and binds all neurotrophins (NGF, BDNF, NT-3, NT-4/5). It plays complex roles in neuron survival, death, and axonal targeting [@sobreviela1994].

TrkA (NTRK1)

The high-affinity NGF receptor, TrkA is essential for NBM neuron development and maintenance. NGF binding to TrkA promotes cholinergic neuron survival and phenotype maintenance [@holtzman1995].

Vesicular Acetylcholine Transporter (VAChT)

VAChT packages acetylcholine into synaptic vesicles for release.

Electrophysiology

NBM neurons exhibit distinctive electrophysiological properties:

• Regular spiking: Relatively slow, regular firing rates (5-15 Hz)
• Burst firing: Can transition to burst mode during salient events
• Persistent activity: Maintains firing during working memory tasks
• Modulation: Activity is modulated by cortical feedback, brainstem arousal systems, and hypothalamic inputs

Vulnerability in Neurodegeneration

Alzheimer's Disease

NBM degeneration is a hallmark of AD:

• Neuron loss: Severe loss of NBM neurons (60-90% in severe AD), correlating with disease severity [@whitehouse1982]
• Amyloid relationship: NBM degeneration correlates with cortical amyloid burden, possibly through toxic effects
• Tau pathology: Neurofibrillary tangles accumulate in NBM neurons following the predictable staging pattern
• Cognitive correlation: Cholinergic deficit strongly correlates with memory and attention impairments

The cholinergic hypothesis of AD, proposed in the 1980s, posits that NBM degeneration and the resulting acetylcholine deficit contribute significantly to cognitive decline. This hypothesis led to the development of acetylcholinesterase inhibitors (AChEIs), which remain first-line symptomatic treatments [@giacobini2000].

Parkinson's Disease and Dementia with Lewy Bodies

• Cognitive decline: NBM degeneration contributes to cognitive impairment in PD and PD with dementia (PDD)
• Attention deficits: Cholinergic loss underlies attention and executive dysfunction
• Lewy bodies: Alpha-synuclein inclusions form in NBM neurons
• DLB: Prominent NBM degeneration in dementia with Lewy bodies, contributing to attentional fluctuations

Other Disorders

• Vascular dementia: NBM vulnerability to white matter ischemia
• Progressive supranuclear palsy: Moderate NBM involvement
• Down syndrome: Early NBM degeneration parallels AD-like pathology

Therapeutic Implications

Current Treatments

Acetylcholinesterase Inhibitors (AChEIs):

• Donepezil (Aricept): Once-daily, approved for mild to severe AD
• Rivastigmine (Exelon): Available as patch, approved for AD and PDD
• Galantamine (Razadyne): Allosteric modulator of nicotinic receptors
• Memantine: NMDA antagonist, often combined with AChEIs

These drugs provide symptomatic benefit by increasing synaptic acetylcholine, partially compensating for lost NBM neurons [@birks2018].

Emerging Therapies

• NGF delivery: Infusing NGF into the NBM to support cholinergic neuron survival. Early trials showed mixed results, but newer approaches using gene therapy (AAV-NGF) are under investigation [@tuszynski2005]
• TrkA agonists: Small molecule TrkA agonists to enhance neurotrophin signaling
• Cell replacement: Transplanting cholinergic progenitors into the basal forebrain
• Anti-amyloid therapies: Reducing amyloid burden may protect NBM neurons

Non-Pharmacological Approaches

• Cognitive stimulation: May enhance cholinergic function
• Deep brain stimulation: Targeting basal forebrain circuits for memory enhancement (experimental)

Background

The study of Nucleus Basalis Of Meynert (Nbm) Cholinergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [Alzheimer's Disease](/diseases/alzheimers-disease) Primary disease affecting NBM
• Acetylcholine - Neurotransmitter produced by NBM neurons
• Cholinesterase Inhibitors - Current AD treatments
• Basal Forebrain- [Parkinson's Disease](/diseases/parkinsons-disease)system
• [Parkinson's Disease](/diseases/parkinsons-disease) NBM involvement in PDD
• Dementia with Lewy Bodies - NBM degeneration
• Donepezil - Common AChEI
• Nerve Growth Factor (NGF))))))))))))))) - Trophic factor for NBM
• Cell-Types/Nucleus-Basalis-Cholinergic-Neurons — This page

Pathway Diagram

The following diagram shows the key molecular relationships involving Nucleus Basalis of Meynert (NBM) Cholinergic Neurons discovered through SciDEX knowledge graph analysis: